41104800L

Organization name

Penta Arzneimittel GmbH

SRN

DE-MF-000006565

Manufacturer status

Active

9 warnings recorded — scroll inside the panel to see all entries.

• CW007

  Do not use the product if single dose container is damaged.
• CW032

  Do not use the eye drops beyond the expiry date which you can find on each single dose container and on each folding box.
• CW010

  Consult instructions for use.
• CW036

  If you also use other eye drops / eye ointment, wait about 15 minutes. These eye drops should always be used last. Remove soft contact lenses before use and reinsert them at the earliest 15 minutes after use.
• CW135

  The eye drops are filled into small plastic containers which could be swallowed by small children. Therefore, please keep the product out of the reach of children.
• CW137

  Do not use in infected and injured eyes.
• CW008

  Do not touch the eye with the single dose container.
• CW129

  Do not use if you are allergic to any of the ingredients.
• CW011

  Temporary blurring for a brief period may be experienced after application; avoid driving, operating machinery and wait until normal vision is restored.

Primary placement in Germany; available across 1 country total.

Trade name

not provided

UDI-DI code

04260595532225

Basic UDI-DI

B-04260595532225

Reference / catalog number

41104800L

Issuing entity

GS1

Risk category

Class IIb

Applicable legislation

MDD [Directive 93/42/EEC on medical devices]

Status

On the market

Quantity

1

Additional product description

Sodium Hyaluronate - Euphrasia Eye Drops (single dose container, 0.4ml) care for and moisturise the ocular surface and alleviate the symptoms of Dry Eye Syndrome.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification

European Medical Device Nomenclature — the EU product classification assigned to this device.

• Q02030301OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES